Axon Biolabs supplies the Retatrutide triple agonist standard ($\text{GIP/GLP-1/GCGR}$) as an advanced chemical reference material for structural biology and bioenergetic research. Retatrutide represents a 39-amino acid synthetic peptide engineered to interact concurrently with three distinct metabolic receptors: GIP, GLP-1, and Glucagon (GCGR). Furthermore, chemists modify this peptide sequence to promote steady receptor engagement during analytical testing.
This multi-target Retatrutide triple agonist standard allows researchers to quantify multi-pathway activation dynamics in cell culture models. Specifically, investigators examine how simultaneous receptor stimulation influences intracellular cAMP pathways. Additionally, scientists benchmarking multi-agonist kinetics often evaluate Retatrutide alongside dual-action compounds like the Tirzepatide dual agonist standard. As a result, research teams can effectively contrast triple-action mechanisms against single or dual agonist profiles.
Technical Profile
-
CAS Registry Number: 2381089-83-2
-
Molecular Formula: C221H342N46O68
-
Molecular Weight: 4731.33 g/mol
-
Purity Level: ≥98.0% (HPLC)
-
Form Factor: Lyophilized white powder
-
Vial Packaging: 5mg / 10mg borosilicate vials
Handling Protocols
Store dry vials at -20°C in a dark environment to maintain compound stability. Furthermore, technicians should avoid ambient moisture entry by allowing vials to reach room temperature prior to unsealing. However, personnel must handle reconstituted samples carefully to prevent degradation. Therefore, researchers should dissolve the compound in aqueous buffer systems appropriate for microplate assay protocols immediately before testing.
Quality Assurance
Axon Biolabs tests each lot using liquid chromatography-mass spectrometry (LC-MS) to verify structural integrity and exact mass. Specifically, our quality control team cross-references sequence models with the NCBI Structure Search database. Therefore, researchers can seamlessly review full batch reports cataloged in our compliance portal.
Regulatory Notice
We supply this chemical strictly for laboratory experimentation, chemical characterization, and in vitro research. Consequently, regulatory guidelines strictly prohibit human, therapeutic, or animal administration under any circumstances.
